您当前的位置：
首页 >
文章列表页 >
Mechanisms of Liuwei Buqi Prescription in Regulating Macrophage Efferocytosis for Treatment of Lung-kidney Qi Deficiency Syndrome in COPD Based on Nrf2/MARCO Signaling Pathway
更新时间：2026-03-03

    • Mechanisms of Liuwei Buqi Prescription in Regulating Macrophage Efferocytosis for Treatment of Lung-kidney Qi Deficiency Syndrome in COPD Based on Nrf2/MARCO Signaling Pathway

    • “Research has found that Liuwei Buqi Formula enhances the phagocytic function of alveolar macrophages in rats by regulating the Nrf2/ARCO pathway, reduces lung and systemic inflammation in COPD rats with lung and kidney qi deficiency, improves lung function, and alleviates lung tissue damage.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 7, Pages: 222-229(2026)

    • DOI：10.13422/j.cnki.syfjx.20252202    

      CLC： R289;R259;R285

    • Received：30 June 2025，

      Revised：2025-09-23，

      Accepted：30 September 2025，

      Online First：09 October 2025，

      Published：05 April 2026

    移动端阅览

  • JIANG Jiankang,WANG Hui,ZHANG Lu,et al.Mechanisms of Liuwei Buqi Prescription in Regulating Macrophage Efferocytosis for Treatment of Lung-kidney Qi Deficiency Syndrome in COPD Based on Nrf2/MARCO Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):222-229. DOI： 10.13422/j.cnki.syfjx.20252202.

  •  
  •  

0

Views

6

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Animal Model of Chronic Obstructive Pulmonary Disease and Intervention Effect of Traditional Chinese Medicine： A Review
Exploring Pathogenesis and Treatment Principles of Chronic Obstructive Pulmonary Disease Based on Spleen-mitochondria Correlation
Anti-inflammatory and Antioxidant Effects and Mechanisms of Baicalin in Rat Model of COPD via NF-κB/Nrf2 Signaling Pathway
Exploration of Pulmonary Vascular Remodeling Improvement in Rats at Different Stages of Chronic Obstructive Pulmonary Disease by Qibai Pingfei Capsules Based on TLR4/NF-κB Signaling Pathway

Related Author

LI Zegeng
TONG Jiabing
WU Fan
ZOU Jiyu
PANG Lijian
WANG Tianjiao
ZANG Ningzi
ZHAO Zhongxue

Related Institution

Anhui Provincial Key Laboratory for Translational Applications in the Prevention and Treatment of Major Pulmonary Diseases with Traditional Chinese Medicine
Institute of Prevention and Treatment of TCM Respiratory Diseases，Anhui Academy of Chinese Medicine
Liaoning University of Traditional Chinese Medicine（TCM）
The Affiliated Hospital of Liaoning University of TCM
Affiliated Hospital of Liaoning University of TCM
0